Related Experiment Video
Updated: May 15, 2026

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Published on: May 5, 2014
New therapeutic strategies in HCV: polymerase inhibitors
Ludmila Gerber1, Tania M Welzel, Stefan Zeuzem
1Klinikum der J.W. Goethe Universität, Frankfurt am Main, Germany.
Abstract:
The characterization of the viral life cycle facilitated the development of directly acting antiviral drugs. Among those, several inhibitors of the viral RNA-dependent RNA polymerase have proven effectiveness in clinical trials. The characteristics of different nucleos(t)ide and non-nucleoside polymerase inhibitors, as well as their clinical applications and combinations with other classes of directly acting antiviral drugs are reviewed herein.
More Related Videos
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
12:03Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Published on: September 5, 2016
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Retrovirus Life Cycles
Hepatitis
Viruses with RNA Genomes
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Inhibitors of Bacterial DNA Synthesis